Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

BUY
$225.52 - $304.06 $1,804 - $2,432
8 Added 1.18%
685 $188,000
Q4 2020

Feb 12, 2021

SELL
$215.97 - $265.89 $4.11 Million - $5.06 Million
-19,040 Reduced 96.57%
677 $173,000
Q3 2020

Nov 13, 2020

SELL
$192.55 - $236.59 $291,328 - $357,960
-1,513 Reduced 7.13%
19,717 $4.66 Million
Q2 2020

Aug 14, 2020

SELL
$159.17 - $224.73 $12,574 - $17,753
-79 Reduced 0.37%
21,230 $4.12 Million
Q1 2020

May 14, 2020

SELL
$130.01 - $216.44 $243,508 - $405,392
-1,873 Reduced 8.08%
21,309 $3.53 Million
Q4 2019

Feb 14, 2020

SELL
$144.81 - $186.0 $5.32 Million - $6.83 Million
-36,742 Reduced 61.31%
23,182 $3.97 Million
Q3 2019

Nov 14, 2019

SELL
$117.35 - $167.95 $6.79 Million - $9.71 Million
-57,839 Reduced 49.11%
59,924 $9.88 Million
Q2 2019

Aug 14, 2019

SELL
$82.13 - $120.73 $584,519 - $859,235
-7,117 Reduced 5.7%
117,763 $14.1 Million
Q1 2019

May 14, 2019

SELL
$72.44 - $101.87 $1.12 Million - $1.57 Million
-15,430 Reduced 11.0%
124,880 $11.9 Million
Q4 2018

Feb 14, 2019

BUY
$73.27 - $105.19 $2.52 Million - $3.62 Million
34,418 Added 32.5%
140,310 $11.1 Million
Q3 2018

Nov 14, 2018

SELL
$81.43 - $108.13 $1.19 Million - $1.58 Million
-14,622 Reduced 12.13%
105,892 $11.2 Million
Q2 2018

Aug 14, 2018

SELL
$83.27 - $101.93 $2.48 Million - $3.04 Million
-29,795 Reduced 19.82%
120,514 $10.3 Million
Q1 2018

May 14, 2018

BUY
$68.49 - $87.2 $4.26 Million - $5.43 Million
62,255 Added 70.7%
150,309 $13 Million
Q4 2017

Feb 13, 2018

SELL
$55.67 - $71.8 $422,980 - $545,536
-7,598 Reduced 7.94%
88,054 $6.08 Million
Q3 2017

Nov 14, 2017

BUY
$49.68 - $59.46 $4.75 Million - $5.69 Million
95,652
95,652 $5.27 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $19B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Next Century Growth Investors LLC Portfolio

Follow Next Century Growth Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Century Growth Investors LLC with notifications on news.